Appleton Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,496
Closed -$645K 303
2019
Q3
$645K Sell
6,496
-1,523
-19% -$145K 0.08% 168
2019
Q2
$741K Sell
8,019
-1,445
-15% -$137K 0.09% 159
2019
Q1
$893K Buy
9,464
+2,173
+30% +$190K 0.12% 141
2018
Q4
$467K Sell
7,291
-3,126
-30% -$231K 0.07% 178
2018
Q3
$932K Sell
10,417
-274
-3% -$24.2K 0.12% 144
2018
Q2
$849K Sell
10,691
-570
-5% -$47.3K 0.12% 151
2018
Q1
$1M Sell
11,261
-301
-3% -$28.9K 0.15% 138
2017
Q4
$1.21M Sell
11,562
-15
-0.1% -$1.69K 0.19% 126
2017
Q3
$1.69M Sell
11,577
-485
-4% -$66.1K 0.28% 91
2017
Q2
$1.57M Buy
12,062
+5,078
+73% +$622K 0.26% 94
2017
Q1
$869K Sell
6,984
-2,244
-24% -$269K 0.16% 128
2016
Q4
$1.07M Sell
9,228
-170
-2% -$18.9K 0.22% 109
2016
Q3
$982K Buy
9,398
+949
+11% +$103K 0.19% 121
2016
Q2
$833K Sell
8,449
-1,614
-16% -$167K 0.17% 113
2016
Q1
$1.01M Sell
10,063
-21
-0.2% -$2.16K 0.2% 98
2015
Q4
$1.21M Buy
10,084
+1,898
+23% +$220K 0.24% 90
2015
Q3
$885K Buy
8,186
+1,500
+22% +$186K 0.2% 98
2015
Q2
$774K Sell
6,686
-420
-6% -$48K 0.17% 102
2015
Q1
$819K Sell
7,106
-94
-1% -$11.2K 0.18% 98
2014
Q4
$805K Buy
7,200
+748
+12% +$78.9K 0.18% 96
2014
Q3
$612K Buy
6,452
+140
+2% +$12.6K 0.14% 107
2014
Q2
$542K Buy
6,312
+250
+4% +$19K 0.13% 119
2014
Q1
$423K Sell
6,062
-600
-9% -$47.5K 0.1% 122
2013
Q4
$563K Buy
6,662
+540
+9% +$42.7K 0.14% 101
2013
Q3
$472K Hold
6,122
0.13% 106
2013
Q2
$358K Buy
+6,122
New +$368K 0.1% 106

Other funds holding CELG

Appleton Partners's CELG Position: Q4 2019 in Review

Appleton Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,496 shares — an estimated $645K sold.

Appleton Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.69M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Appleton Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Appleton Partners sold 6,496 Celgene Corp shares in Q4 2019, an estimated $645K.
  • Appleton Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Appleton Partners's Celgene Corp position peaked at $1.69M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Appleton Partners's 13F filing for Q4 2019, filed 13 Jan 2020.